TUBEX® is getting wider recognition and awareness – Now on social Media. | IDL Biotech
IDL Biotech

CLOSE MENU

Articles

Typhiod fever

September 2015

TUBEX® is getting wider recognition and awareness – Now on social Media.

TUBEX® is getting wider recognition and awareness – Now on social Media.

As an example has one of our partners, PT. Pacific Biotekindo Intralab during the autumn organized a photo contest named “TUBEX® & Me” among the users of TUBEX® TF in Indonesia.  More than 275 photos have been uploaded on Instagram and Facebook by enthusiastic participants.

According to Lutfatul Farhati, the product manager at PT Pacific Biotekindo, is this event one part in their programme to maintain the Brand Awareness of TUBEX® TF in Indonesia. “The goal of this contest is to get customer closer by giving rewards and keep good relationship with loyal customer” she also says.

You will find more photos under #tubex­_tf on Instagram.

IDL Biotech includes additional clinics in its ongoing multicenter study for UBC® Rapid in Sweden.

IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC® Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk.

IDL Biotech signs distributor agreements in Rwanda, South Sudan and Somalia

IDL Biotech continues to expand in Africa. Today, IDL Biotech has signed a distributor agreement with Roi Scientific Ltd covering Rwanda, South Sudan and Somalia. The agreement covers the sale of TUBEX® TF.

IDL Biotech

Skip this intro